Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...
Jim Tananbaum, MD and the Founder and CEO of Foresite Capital, a US-focused health-care investment firm says the sector is ...
Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.
The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
End-to-end automation could offer significant benefits: speed, accuracy, and scalability. Digital workers perform repetitive ...
Patients are looking to pharmaceutical companies to offer healthcare services beyond just drug development, and, ideally, in ...
US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback